Clinical Trials

A Phase 1, open-label trial of belzupacap sarotalocan (AU-011) to determine the feasibility and safety of intratumoral injection with or without intramural injection in subjects with bladder cancer (CTMS#22-0121)

ClinicalTrials.gov Identifier

ClinicalTrials.gov registration not required

Principal Investigator

Ahmed Mansour Elkenany MD

For more information about this study
View Details

About This Study